PMID: 7538671May 9, 1995Paper

Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide

Proceedings of the National Academy of Sciences of the United States of America
M A SchwarzJ R Lancaster

Abstract

In inflammatory states, nitric oxide (.NO) may be synthesized from precursor L-arginine via inducible .NO synthase (iNOS) in large amounts for prolonged periods of time. When .NO acts as an effector molecule under these conditions, it may be toxic to cells by inhibition of iron-containing enzymes or initiation of DNA single-strand breaks. In contrast to molecular targets of .NO, considerably less is known regarding mechanisms by which cells become resistant to .NO. Metallothionein (MT), the major protein thiol induced in cells exposed to cytokines and bacterial products, is capable of forming iron-dinitrosyl thiolates in vitro. Therefore, we tested the hypothesis that overexpression of MT reduces the sensitivity of NIH 3T3 cells to the .NO donor, S-nitrosoacetylpenicillamine (SNAP), and to .NO released from cells (NIH 3T3-DFG-iNOS) after infection with a retroviral vector expressing human iNOS gene. There was a 4-fold increase in MT in cells transfected with the mouse MT-1 gene (NIH 3T3/MT) compared to cells transfected with the promoter-free inverted gene (NIH 3T3/TM). NIH 3T3/MT cells were more resistant than NIH 3T3/TM cells to the cytotoxic effects of SNAP (0.1-1.0 mM) or .NO released from NIH 3T3-DFG-iNOS cells. A brief (1...Continue Reading

References

Oct 19, 1976·Biochemistry·K W KohnC A Friedman
Dec 18, 1992·Science·J S StamlerJ Loscalzo
Nov 1, 1992·Chemical Research in Toxicology·W H KoppenolJ S Beckman
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J S StamlerJ Loscalzo
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·T NguyenS R Tannenbaum
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M S MulliganP A Ward
Aug 1, 1991·Archives of Biochemistry and Biophysics·R RadiB A Freeman
Feb 11, 1991·Current Opinion in Immunology·C F Nathan, J B Hibbs
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
Jan 1, 1990·Annual Review of Nutrition·I Bremner, J H Beattie
Jul 1, 1987·Carcinogenesis·M MiwaS R Tannenbaum
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·J R Lancaster
Apr 1, 1993·Free Radical Biology & Medicine·C CazevieilleC Bonne
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D A WinkJ B Mitchell
Oct 29, 1993·Biochemical and Biophysical Research Communications·M C KennedyD H Petering
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K T TamaiD J Thiele
Mar 1, 1993·Free Radical Biology & Medicine·M Sato, I Bremner

❮ Previous
Next ❯

Citations

Apr 25, 2001·Journal of Cellular Physiology·A J Gow, H Ischiropoulos
Jan 7, 2000·Biochemical and Biophysical Research Communications·J M KimS Kim
Mar 10, 2000·Biochemical and Biophysical Research Communications·J M KimS Kim
Aug 31, 2000·Molecular Neurobiology·X J Li
Jun 10, 2004·Pathology Oncology Research : POR·Rongxian JinBoon-Huat Bay
Jan 13, 2004·Neurotoxicity Research·B Gabryel, H I Trzeciak
Aug 4, 2010·Applied Microbiology and Biotechnology·Mitchell Lawrence JonesSatya Prakash
Jul 27, 2007·Cardiovascular Toxicology·Y James Kang
Jan 1, 1996·Free Radical Biology & Medicine·S LuperchioS R Tannenbaum
Nov 1, 1995·Research in Immunology·A K NusslerT R Billiar
Nov 1, 1995·Research in Immunology·K FehselV Kolb-Bachofen
Dec 4, 2003·Free Radical Biology & Medicine·Olga SidorkinaJacques Laval
Jan 23, 2002·Journal of Inorganic Biochemistry·Kazuo T SuzukiYasumitsu Ogra
Jan 23, 2002·Journal of Inorganic Biochemistry·Klaus Zangger, Ian M Armitage
Jun 1, 2000·Journal of Inorganic Biochemistry·K M MirandaD A Wink
Nov 6, 2002·Journal of Neuroimmunology·Akira TeraoYvonne R Freund
Jul 27, 2001·Brain Research Bulletin·J HidalgoM Vasák
Jul 20, 2002·FEMS Microbiology Letters·Marie R B BinetRobert K Poole
Apr 10, 2003·Free Radical Biology & Medicine·Keping Xie, Suyun Huang
Jan 22, 1998·Free Radical Biology & Medicine·J B WeinbergW Chamulitrat
Jun 26, 1998·Mutation Research·W LinZ Zhou
Aug 21, 2001·Breast Cancer Research and Treatment·R JinP H Tan
Feb 26, 2010·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Michael Aschner, George C-T Jiang
Jun 9, 2001·Antioxidants & Redox Signaling·E Bourdon, D Blache
Mar 10, 2001·Antioxidants & Redox Signaling·C M PayneH Garewal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.